Natixis Advisors, L.P. Covetrus, Inc. Transaction History

Natixis Advisors, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$20.69 - $20.91 $39,786 - $40,209	-1,923 Reduced 7.53%	23,626 $493,000
Q2 2022 Aug 12, 2022	BUY	$13.8 - $20.82 $154,173 - $232,601	11,172 Added 77.71%	25,549 $530,000
Q1 2022 May 12, 2022	BUY	$15.96 - $18.87 $229,456 - $271,293	14,377 New	14,377 $241,000
Q3 2021 Nov 15, 2021	SELL	$18.14 - $27.03 $232,645 - $346,659	-12,825 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$25.24 - $30.86 $23,321 - $28,514	-924 Reduced 6.72%	12,825 $346,000
Q1 2021 May 05, 2021	SELL	$28.29 - $39.89 $22,632 - $31,912	-800 Reduced 5.5%	13,749 $412,000
Q4 2020 Feb 12, 2021	SELL	$24.45 - $31.59 $562 - $726	-23 Reduced 0.16%	14,549 $418,000
Q3 2020 Nov 12, 2020	BUY	$17.22 - $24.59 $250,929 - $358,325	14,572 New	14,572 $356,000

72.9K

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Natixis Advisors, L.P. with notifications on news.